Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification

D Wilkin Parke III, Robert A Sisk, Samuel K Houston, Timothy G MurrayDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USAObjective: To evaluate the effect of adjunctive intravitreal triamcinolone (IVTA) on intraocular pressure (IOP)...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Parke III DW, Sisk RA, Houston SK, Murray TG
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/1e7c9816aa4b4bc4a2604da2b6d49dfe
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1e7c9816aa4b4bc4a2604da2b6d49dfe
record_format	dspace
spelling	oai:doaj.org-article:1e7c9816aa4b4bc4a2604da2b6d49dfe2021-12-02T01:36:27ZOcular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification1177-54671177-5483https://doaj.org/article/1e7c9816aa4b4bc4a2604da2b6d49dfe2012-06-01T00:00:00Zhttp://www.dovepress.com/ocular-hypertension-after-intravitreal-triamcinolone-with-vitrectomy-a-a10141https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483D Wilkin Parke III, Robert A Sisk, Samuel K Houston, Timothy G MurrayDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USAObjective: To evaluate the effect of adjunctive intravitreal triamcinolone (IVTA) on intraocular pressure (IOP) in the setting of combined vitrectomy with phacoemulsification.Design: Retrospective case series.Participants: One hundred thirty-one consecutive eyes undergoing nonemergent vitrectomy with phacoemulsification and IVTA were reviewed and included in the analysis. All 131 eyes received 4 mg IVTA at the end of surgery.Methods: Pre- and postoperative IOP, use of pressure-lowering medications, and rate of glaucoma surgery were analyzed. Pre-operative risk factors were analyzed.Main outcome measures: IOP, glaucoma medications, or glaucoma surgery.Results: Secondary ocular hypertension (defined as IOP &ge;25 mmHg) was found in 28 eyes (21%), the majority during postoperative day 1 only. Twelve eyes (9%) had an elevated IOP measurement noted at a visit after the first postoperative day. Five (4%) had an IOP rise of &ge;10 mmHg over baseline at any time after postoperative day 1. Six (5%) required glaucoma medications. One eye required a glaucoma drainage implant for diabetic neovascular angle closure glaucoma, and one eye required enucleation for intractable neovascular glaucoma due to radiation retinopathy. Elevated postoperative IOP was statistically associated with higher baseline IOP and presence of preoperative glaucoma.Conclusions: Therapeutic intravitreal triamcinolone with combined vitrectomy and phacoemulsification causes infrequent and usually mild secondary ocular hypertension. Secondary ocular hypertension is associated with preoperative glaucoma and high IOP.Keywords: glaucoma, cataract, inflammationParke III DWSisk RAHouston SKMurray TGDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2012, Iss default, Pp 925-931 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Parke III DW Sisk RA Houston SK Murray TG Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
description	D Wilkin Parke III, Robert A Sisk, Samuel K Houston, Timothy G MurrayDepartment of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, Miami, FL, USAObjective: To evaluate the effect of adjunctive intravitreal triamcinolone (IVTA) on intraocular pressure (IOP) in the setting of combined vitrectomy with phacoemulsification.Design: Retrospective case series.Participants: One hundred thirty-one consecutive eyes undergoing nonemergent vitrectomy with phacoemulsification and IVTA were reviewed and included in the analysis. All 131 eyes received 4 mg IVTA at the end of surgery.Methods: Pre- and postoperative IOP, use of pressure-lowering medications, and rate of glaucoma surgery were analyzed. Pre-operative risk factors were analyzed.Main outcome measures: IOP, glaucoma medications, or glaucoma surgery.Results: Secondary ocular hypertension (defined as IOP &ge;25 mmHg) was found in 28 eyes (21%), the majority during postoperative day 1 only. Twelve eyes (9%) had an elevated IOP measurement noted at a visit after the first postoperative day. Five (4%) had an IOP rise of &ge;10 mmHg over baseline at any time after postoperative day 1. Six (5%) required glaucoma medications. One eye required a glaucoma drainage implant for diabetic neovascular angle closure glaucoma, and one eye required enucleation for intractable neovascular glaucoma due to radiation retinopathy. Elevated postoperative IOP was statistically associated with higher baseline IOP and presence of preoperative glaucoma.Conclusions: Therapeutic intravitreal triamcinolone with combined vitrectomy and phacoemulsification causes infrequent and usually mild secondary ocular hypertension. Secondary ocular hypertension is associated with preoperative glaucoma and high IOP.Keywords: glaucoma, cataract, inflammation
format	article
author	Parke III DW Sisk RA Houston SK Murray TG
author_facet	Parke III DW Sisk RA Houston SK Murray TG
author_sort	Parke III DW
title	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
title_short	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
title_full	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
title_fullStr	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
title_full_unstemmed	Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
title_sort	ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification
publisher	Dove Medical Press
publishDate	2012
url	https://doaj.org/article/1e7c9816aa4b4bc4a2604da2b6d49dfe
work_keys_str_mv	AT parkeiiidw ocularhypertensionafterintravitrealtriamcinolonewithvitrectomyandphacoemulsification AT siskra ocularhypertensionafterintravitrealtriamcinolonewithvitrectomyandphacoemulsification AT houstonsk ocularhypertensionafterintravitrealtriamcinolonewithvitrectomyandphacoemulsification AT murraytg ocularhypertensionafterintravitrealtriamcinolonewithvitrectomyandphacoemulsification
_version_	1718402943770689536

Ocular hypertension after intravitreal triamcinolone with vitrectomy and phacoemulsification

Ejemplares similares